CoChat
Sign Up
Cited by 104Neuroinflammation and Neurodegeneration MechanismsNeonatal and fetal brain pathologyNeonatal and Maternal Infections

The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.

Systemic inflammation in early neonatal mice induces transient and lasting neurodegenerative effects

Open access
Cardoso, Filipa L, Herz, Jasmin, Fernandes, Adelaide, Rocha, João, Sepodes, Bruno, Brito, Maria A, McGavern, Dorian B, Brites, Dora·2015·Journal of Neuroinflammation
DOI 10.1186/s12974-015-0299-3PMC PMC4440597
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: The inflammatory mediator lipopolysaccharide (LPS) has been shown to induce acute gliosis in neonatal mice. However, the progressive effects on the murine neurodevelopmental program over the week that follows systemic inflammation are not known. Thus, we investigated the effects of repeated LPS administration in the first postnatal week in mice, a condition mimicking sepsis in late preterm infants, on the developing central nervous system (CNS). METHODS: Systemic inflammation was induced by daily intraperitoneal administration (i.p.) of LPS (6 mg/kg) in newborn mice from postnatal day (PND) 4 to PND6. The effects on neurodevelopment were examined by staining the white matter and neurons with Luxol Fast Blue and Cresyl Violet, respectively. The inflammatory response was assessed by quantifying the expression/activity of matrix metalloproteinases (MMP), toll-like receptor (TLR)-4, high mobility group box (HMGB)-1, and autotaxin (ATX). In addition, B6 CX3CR1(gfp/+) mice combined with cryo-immunofluorescence were used to determine the acute, delayed, and lasting effects on myelination, microglia, and astrocytes. RESULTS: LPS administration led to acute body and brain weight loss as well as overt structural changes in the brain such as cerebellar hypoplasia, neuronal loss/shrinkage, and delayed myelination. The impaired myelination was associated with alterations in the proliferation and differentiation of NG2 progenitor cells early after LPS administration, rather than with excessive phagocytosis by CNS myeloid cells. In addition to disruptions in brain architecture, a robust inflammatory response to LPS was observed. Quantification of inflammatory biomarkers revealed decreased expression of ATX with concurrent increases in HMGB1, TLR-4, and MMP-9 expression levels. Acute astrogliosis (GFAP(+) cells) in the brain parenchyma and at the microvasculature interface together with parenchymal microgliosis (CX3CR1(+) cells) were also observed. These changes preceded the migration/proliferation of CX3CR1(+) cells around the vessels at later time points and the subsequent loss of GFAP(+) astrocytes. CONCLUSION: Collectively, our study has uncovered a complex innate inflammatory reaction and associated structural changes in the brains of neonatal mice challenged peripherally with LPS. These findings may explain some of the neurobehavioral abnormalities that develop following neonatal sepsis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12974-015-0299-3

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic representation of the early induction of systemic inflammation. Offspring of both genders were randomly divided into two groups and treated with three intraperitoneal injections of either saline solution or lipopolysaccharide (LPS) at days 4, 5, and 6 after birth to induce systemic inflammation. CD1 wild-type mice were sacrificed at 1 and 9 days after LPS injections, and C57BL/6 (B6) CX3CR1gfp/+ mice were sacrificed at days 1/3/5/6/7/9 following LPS administration.
Figure 1 Schematic representation of the early induction of systemic inflammation. Offspring of both genders were randomly divided into two groups and treated with three intraperitoneal injections of either saline solution or lipopolysaccharide (LPS) at days 4, 5, and 6 after birth to induce systemic inflammation. CD1 wild-type mice were sacrificed at 1 and 9 days after LPS injections, and C57BL/6 (B6) CX3CR1gfp/+ mice were sacrificed at days 1/3/5/6/7/9 following LPS administration.CC BY · PubMed Central
Figure 2 Early lipopolysaccharide (LPS) administration causes transient body and brain weight loss and decreases the cerebellar area. (A) Body and brain of CD1 wild-type mice were weighed at 1 and 9 days post-LPS administration. (B) Body weight of C57BL/6 (B6) CX3CR1gfp/+ mice was assessed at days 1/3/5/7/9 after LPS injection. (C) Cerebellar area was measured in tiled confocal images of brain sections from B6 CX3CR1gfp/+ mice at days 1/3/5/7/9 post-LPS (representative images with DAPI in (D). Results are mean ± SEM from at least four animals. **P < 0.01 vs. without (W/O) LPS.
Figure 2 Early lipopolysaccharide (LPS) administration causes transient body and brain weight loss and decreases the cerebellar area. (A) Body and brain of CD1 wild-type mice were weighed at 1 and 9 days post-LPS administration. (B) Body weight of C57BL/6 (B6) CX3CR1gfp/+ mice was assessed at days 1/3/5/7/9 after LPS injection. (C) Cerebellar area was measured in tiled confocal images of brain sections from B6 CX3CR1gfp/+ mice at days 1/3/5/7/9 post-LPS (representative images with DAPI in (D). Results are mean ± SEM from at least four animals. **P < 0.01 vs. without (W/O) LPS.CC BY · PubMed Central
Figure 3 Lipopolysaccharide (LPS) administration triggers transient shrinkage of cerebellar layers, acute neuronal loss, and sustained atrophy. Paraffin sections from CD1 wild-type mice at 1 and 9 days post-LPS administration were stained with Luxol Fast Blue (myelin, blue) followed by Cresyl Violet (Nissl bodies, purple). (A) Representative images are shown for each condition in the pons, hippocampus, and cerebellum. (B) The widths of each cerebellar layer [external germinal layer (EGL), molecular layer (ML), Purkinje layer, internal granular layer (IGL), white matter layer (WML)] were measured. (C,D) Intensity of Cresyl Violet staining in the EGL and of Luxol Fast Blue in WML were quantified per square micrometer at 1 and 9 days after LPS administration, respectively. (E,F) The number of neurons per field and the area of neuronal cell body (soma) was quantified throughout the pons, in the CA3 hippocampal region, and in the cerebellar Purkinje layer (PL). All determinations were done using ImageJ software (NIH, USA). Results are mean ± SEM from at least five animals. *P < 0.05 vs. without (W/O) LPS.
Figure 3 Lipopolysaccharide (LPS) administration triggers transient shrinkage of cerebellar layers, acute neuronal loss, and sustained atrophy. Paraffin sections from CD1 wild-type mice at 1 and 9 days post-LPS administration were stained with Luxol Fast Blue (myelin, blue) followed by Cresyl Violet (Nissl bodies, purple). (A) Representative images are shown for each condition in the pons, hippocampus, and cerebellum. (B) The widths of each cerebellar layer [external germinal layer (EGL), molecular layer (ML), Purkinje layer, internal granular layer (IGL), white matter layer (WML)] were measured. (C,D) Intensity of Cresyl Violet staining in the EGL and of Luxol Fast Blue in WML were quantified per square micrometer at 1 and 9 days after LPS administration, respectively. (E,F) The number of neurons per field and the area of neuronal cell body (soma) was quantified throughout the pons, in the CA3 hippocampal region, and in the cerebellar Purkinje layer (PL). All determinations were done using ImageJ software (NIH, USA). Results are mean ± SEM from at least five animals. *P < 0.05 vs. without (W/O) LPS.CC BY · PubMed Central
Figure 4 Lipopolysaccharide (LPS) administration disrupts myelination in the cerebellum and pons of neonatal mice. Brain cryosections from C57BL/6 CX3CR1gfp/+ mice at days 1/3/5/7/9 post-LPS administration were immunolabeled for myelin (myelin basic protein, MBP, red). Representative confocal images of the cerebellum and pons are displayed in (A), where the overlapping of MBP and microglial marker CX3CR1 (green) is seen in yellow. (B) Area fraction per field of MBP staining was quantified per region using ImageJ software (NIH, USA). (C) To assess microglial phagocytosis, confocal images at days LPS1 and LPS3 were amplified (overlapping of MBP and CX3CR1 is visible in yellow). Sections of animals at LPS1 were immunolabeled for apoptosis (ApopTag, red) and oligodendrocytes precursor cells (NG2 cells, green). (D) Cerebellar layers are identified [external germinal layer (EGL), molecular layer (ML), Purkinje layer, internal granular layer (IGL)]. (E) Area fraction per field of ApopTag and of NG2 positive stainings were determined using ImageJ software (NIH, USA). *P < 0.05 and **P < 0.01 vs. without (W/O) LPS.
Figure 4 Lipopolysaccharide (LPS) administration disrupts myelination in the cerebellum and pons of neonatal mice. Brain cryosections from C57BL/6 CX3CR1gfp/+ mice at days 1/3/5/7/9 post-LPS administration were immunolabeled for myelin (myelin basic protein, MBP, red). Representative confocal images of the cerebellum and pons are displayed in (A), where the overlapping of MBP and microglial marker CX3CR1 (green) is seen in yellow. (B) Area fraction per field of MBP staining was quantified per region using ImageJ software (NIH, USA). (C) To assess microglial phagocytosis, confocal images at days LPS1 and LPS3 were amplified (overlapping of MBP and CX3CR1 is visible in yellow). Sections of animals at LPS1 were immunolabeled for apoptosis (ApopTag, red) and oligodendrocytes precursor cells (NG2 cells, green). (D) Cerebellar layers are identified [external germinal layer (EGL), molecular layer (ML), Purkinje layer, internal granular layer (IGL)]. (E) Area fraction per field of ApopTag and of NG2 positive stainings were determined using ImageJ software (NIH, USA). *P < 0.05 and **P < 0.01 vs. without (W/O) LPS.CC BY · PubMed Central
Figure 5 Lipopolysaccharide (LPS) challenge promotes differential expression of inflammatory biomarkers in the brain. Whole brain lysates of CD1 wild-type mice at 1 day post-lipopolysaccharide (LPS) administration were used to determine the activities of metalloproteinase(MMP)-9 and MMP-2 by gelatin zymography, alongside with the expression of toll-like receptor (TLR)-4, high-mobility group box 1 (HMGB1) and autotaxin (ATX) by western blot. Results are expressed as fold-change from animals without (W/O) LPS, and are mean ± SEM from at least four animals in each group. *P < 0.05 and **P < 0.01 vs. W/O LPS.
Figure 5 Lipopolysaccharide (LPS) challenge promotes differential expression of inflammatory biomarkers in the brain. Whole brain lysates of CD1 wild-type mice at 1 day post-lipopolysaccharide (LPS) administration were used to determine the activities of metalloproteinase(MMP)-9 and MMP-2 by gelatin zymography, alongside with the expression of toll-like receptor (TLR)-4, high-mobility group box 1 (HMGB1) and autotaxin (ATX) by western blot. Results are expressed as fold-change from animals without (W/O) LPS, and are mean ± SEM from at least four animals in each group. *P < 0.05 and **P < 0.01 vs. W/O LPS.CC BY · PubMed Central
Figure 6 Morphological changes in microglia following lipopolysaccharide (LPS) administration. (A) Representative confocal images of CX3CR1+ cell morphology from brain cryosections of C57BL/6 CX3CR1gfp/+ mice at days 1/3/5/7/9 post-lipopolysaccharide (LPS) administration are shown. (B,C) Using ImageJ software (NIH, USA), we performed Scholl analysis (>40 cells per animal) at days 1 and 9 post-LPS administration. Results are mean ± SEM from at least four animals. *P < 0.05 and **P < 0.01 vs. without (W/O) LPS; § P < 0.05 and §§ P < 0.01 vs. day 1 post-LPS.
Figure 6 Morphological changes in microglia following lipopolysaccharide (LPS) administration. (A) Representative confocal images of CX3CR1+ cell morphology from brain cryosections of C57BL/6 CX3CR1gfp/+ mice at days 1/3/5/7/9 post-lipopolysaccharide (LPS) administration are shown. (B,C) Using ImageJ software (NIH, USA), we performed Scholl analysis (>40 cells per animal) at days 1 and 9 post-LPS administration. Results are mean ± SEM from at least four animals. *P < 0.05 and **P < 0.01 vs. without (W/O) LPS; § P < 0.05 and §§ P < 0.01 vs. day 1 post-LPS.CC BY · PubMed Central
Figure 7 Early increased vessel coverage by glia is followed by delayed astrocytic loss and parenchymal microgliosis. Brain cryosections of C57BL/6 CX3CR1gfp/+ mice at days 1/3/5/7/9 post-lipopolysaccharide (LPS) administration were immunolabeled for astrocytes (glial fibrillary acidic protein, GFAP, red) along with vessel marker CD31 (cluster of differentiation 31, gray). Representative confocal images of glia-endothelium interactions in pons are displayed in (A). (B,C) Area fraction per field of GFAP and CX3CR1 (green) positive staining, as well as their respective colocalization with the vessels were determined by ImageJ software (NIH, USA). Results are mean ± SEM from at least four animals. *P < 0.05 and **P < 0.01 vs. without (W/O) LPS.
Figure 7 Early increased vessel coverage by glia is followed by delayed astrocytic loss and parenchymal microgliosis. Brain cryosections of C57BL/6 CX3CR1gfp/+ mice at days 1/3/5/7/9 post-lipopolysaccharide (LPS) administration were immunolabeled for astrocytes (glial fibrillary acidic protein, GFAP, red) along with vessel marker CD31 (cluster of differentiation 31, gray). Representative confocal images of glia-endothelium interactions in pons are displayed in (A). (B,C) Area fraction per field of GFAP and CX3CR1 (green) positive staining, as well as their respective colocalization with the vessels were determined by ImageJ software (NIH, USA). Results are mean ± SEM from at least four animals. *P < 0.05 and **P < 0.01 vs. without (W/O) LPS.CC BY · PubMed Central
Figure 8 Astrocytic loss in neonatal inflammation is preceded by proliferation/migration of CX3CR1+ cells in the pons. Brain cryosections of C57BL/6 CX3CR1gfp/+ mice at day 6 post-lipopolysaccharide (LPS) administration were immunolabeled for astrocytes (glial fibrillary acidic protein, GFAP, red) and brain microvascular endothelial cells (cluster of differentiation, CD31, gray). Representative confocal images of each condition in the pons are depicted in (A). (B,C) Area fraction per field of GFAP and CX3CR1 (green) positive staining, along with their respective colocalization with vessels, were determined using ImageJ software (NIH, USA). Representative confocal images of sections immunolabeled for astrocytes (GFAP, red) and for ApopTag (gray) are depicted in (D). Quantification of ApopTag+ staining area fraction, using the abovementioned software, is shown in (E). Results are mean ± SEM from at least four animals. **P < 0.01 vs. without (W/O) LPS; § P < 0.05 and §§ P < 0.01 vs. day 5 post-LPS.
Figure 8 Astrocytic loss in neonatal inflammation is preceded by proliferation/migration of CX3CR1+ cells in the pons. Brain cryosections of C57BL/6 CX3CR1gfp/+ mice at day 6 post-lipopolysaccharide (LPS) administration were immunolabeled for astrocytes (glial fibrillary acidic protein, GFAP, red) and brain microvascular endothelial cells (cluster of differentiation, CD31, gray). Representative confocal images of each condition in the pons are depicted in (A). (B,C) Area fraction per field of GFAP and CX3CR1 (green) positive staining, along with their respective colocalization with vessels, were determined using ImageJ software (NIH, USA). Representative confocal images of sections immunolabeled for astrocytes (GFAP, red) and for ApopTag (gray) are depicted in (D). Quantification of ApopTag+ staining area fraction, using the abovementioned software, is shown in (E). Results are mean ± SEM from at least four animals. **P < 0.01 vs. without (W/O) LPS; § P < 0.05 and §§ P < 0.01 vs. day 5 post-LPS.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 117 references

Cited by

Sorted by citations

Items 101–104 of 104

Related

See all

Metadata

Authors
Cardoso, F. L., Herz, J., Fernandes, A., Rocha, J., Sepodes, B., Brito, M. A., McGavern, D. B., & Brites, D.
Affiliations
  • University of Lisbon (PT)
  • National Institutes of Health (US)
Corresponding author
  • McGavern, Dorian B
  • Brites, Dora
ORCID
Venue
Journal of Neuroinflammation
Publisher
Springer Science and Business Media LLC
Published
2015-04-29
Volume
12
Issue
1
Pages
82-82
ISSN
1742-2094 (ISSN-L)
DOI
10.1186/s12974-015-0299-3
PMC
PMC4440597
OpenAlex
W2031096177
Cited by
103
References
117
Citations by year
2026: 4 · 2025: 3 · 2024: 7 · 2023: 13 · 2022: 13 · 2021: 3 · 2020: 18 · 2019: 12 · 2018: 6 · 2017: 13 · 2016: 10 · 2015: 1
FWCI
5.33
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Universidade de Lisboa
  • Fundação Luso-Americana para o Desenvolvimento
  • National Institutes of Health
  • Fundação para a Ciência e a Tecnologia (COMPETE, PTDC/SAU-FAR/118787/2010, SFRH/BD/62959/2009, /2009)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
Keywords
systemic inflammation, lipopolysaccharide, neonatal sepsis, brain development, myelination, cerebellar hypoplasia, neuroinflammation, astrocyte activation, microglial activation, autotaxin, HMGB1, TLR4, MMP-9, CX3CR1, astrocyte loss
MeSH terms
CX3C Chemokine Receptor 1, Age Factors, Anethole Trithione, Animals, Animals, Newborn, Body Weight, Cerebellum, Developmental Disabilities, Demyelinating Diseases, Myelin Basic Protein, Gene Expression Regulation, Inflammation, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Nervous System Malformations, Time Factors, Microglia, Neurodegenerative Diseases, Receptors, Chemokine, HMGB1 Protein, Green Fluorescent Proteins, Toll-Like Receptor 4, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review